Skip to main content

ADVERTISEMENT

Real-World Outcomes

High Costs of Pancreatic Enzyme Replacement Therapy Barrier to Medicare Beneficiary Drug Access
Videos
01/20/2021
Arjun Gupta, MD, discusses results from a study assessing out-of-pocket and total spending on pancreatic enzyme replacement therapy under Medicare Part D.
Arjun Gupta, MD, discusses results from a study assessing out-of-pocket and total spending on pancreatic enzyme replacement therapy under Medicare Part D.
Arjun Gupta, MD, discusses...
01/20/2021
Journal of Clinical Pathways
Conference Coverage
01/16/2021
Journal of Clinical Pathways
Real-World Biomarker Testing, Treatment Patterns in CLL/SLL
Videos
12/17/2020
Anthony Mato, MD, discusses prognostic biomarker testing, treatment practices, and outcomes among patients with CLL in the clinical practice setting, using the informCLL prospective registry.
Anthony Mato, MD, discusses prognostic biomarker testing, treatment practices, and outcomes among patients with CLL in the clinical practice setting, using the informCLL prospective registry.
Anthony Mato, MD, discusses...
12/17/2020
Journal of Clinical Pathways
Conference Coverage
12/09/2020
Journal of Clinical Pathways
News
07/16/2020
Cutaneous adverse events (AEs) from anti-CTLA4 and anti-PD1 combination therapy for metastatic melanoma are mostly mild and can be managed using topical steroids and/or oral histamines, according to a study published...
Cutaneous adverse events (AEs) from anti-CTLA4 and anti-PD1 combination therapy for metastatic melanoma are mostly mild and can be managed using topical steroids and/or oral histamines, according to a study published...
...
07/16/2020
Journal of Clinical Pathways
Interview
08/19/2019
JCP Editors
Randomized clinical trials (RCTs) use a well-established methodology for gathering robust evidence of the safety and efficacy of medical interventions. They remain the “gold standard” of data for evaluating new...
Randomized clinical trials (RCTs) use a well-established methodology for gathering robust evidence of the safety and efficacy of medical interventions. They remain the “gold standard” of data for evaluating new...
...
08/19/2019
Journal of Clinical Pathways
Research in Review
07/28/2017
JCP Editors
Researchers compared the relationship between randomized controlled clinical trial efficacy data and real-world effectiveness for oncology therapies, published in Value in Health (July-August,...
Researchers compared the relationship between randomized controlled clinical trial efficacy data and real-world effectiveness for oncology therapies, published in Value in Health (July-August,...
...
07/28/2017
Journal of Clinical Pathways
Research in Review
07/19/2017
JCP Editors
Recent research suggests that 73% of patients with cancer do not discuss the cost of care with their care team, published by the Cancer Support Community (July 18, 2017). ----- Related Content Improving Patient...
Recent research suggests that 73% of patients with cancer do not discuss the cost of care with their care team, published by the Cancer Support Community (July 18, 2017). ----- Related Content Improving Patient...
Recent...
07/19/2017
Journal of Clinical Pathways